Antiphospholipid Syndrome Increases Postoperative Complications After Total Hip and Knee Arthroplasty

Abstract

Background: Antiphospholipid syndrome (APS) is a systemic autoimmune condition that predisposes patients to venous thromboembolism (VTE). Although many studies have explored risk factors for VTE after joint reconstructive procedures, the impact of APS is still unclear. Materials and Methods: A retrospective cohort study was conducted using TriNetX, a health care database that includes 442,494 patients undergoing total hip arthroplasty (THA) or total knee arthroplasty (TKA). Ninety-day postoperative complications and 1- and 2-year surgical complications were compared between patients with and without preexisting APS. Patients underwent propensity score matching in a 1:1 ratio based on relevant comorbidities. Results: Patients undergoing THA or TKA with APS, compared with those without, had higher rates of deep venous thrombosis (hip: 9.2% vs 6.0%, odds ratio, 1.589, P =.022; knee: 10.5% vs 4.1%, odds ratio, 2.763, P <.001), pulmonary embolism (hip: 6.9% vs 3.6%, odds ratio, 1.992, P =.005; knee: 8.4% vs 3.0%, odds ratio, 2.989, P <.001), and anemia (hip: 24.8% vs 18.6%, odds ratio, 1.447, P =.004; knee: 18.5% vs 13.9%, odds ratio, 1.406, P =.007). Patients undergoing THA with APS also had higher rates of urinary tract infection (5.0% vs 2.8%, odds ratio, 1.842, P =.029) and pneumonia (3.7% vs 1.8%, odds ratio, 2.119, P =.025). APS did not impact rates of surgical complications or revision surgery. Conclusion: Overall, APS heightens patients' risk for complications after THA and TKA. Specific anticoagulation protocols and preoperative risk stratification should be implemented to reduce the risk of adverse events. [ Orthopedics . 202;4x(x):xx–xx.]